Health & Fitness 'Thousands will die' because of a huge cancer care backlog
Twin blasts that rein in terminal prostate cancer
One patient in the trial, David Livingstone, 68, was diagnosed in 2016 with prostate cancer. He was given six months to live - but the ex-photographer from Northern Ireland is still alive five years later. He said: ‘Since my diagnosis, I have seen my two daughters get married and I now have two wonderful grandchildren. Without this treatment I’d be long gone.
Thousands of cancer patients will die over the next decade because of the devastating treatment backlog caused by the pandemic, a damning report has revealed.
Around 19,500 people in England with cancer have not yet been diagnosed due to Covid-related disruption to the.
It could take more than a decade to clear this ‘missing cancer patients backlog’, according to analysis by Institute for Public Policy Research and the CF healthcare consultancy.
They calculated that even if ‘stretched’ hospitals conducted 5 per cent more treatments than pre-pandemic levels, it will take until 2033 to catch up with the cancer backlog.
NHS England chief warns public not to delay coming forward for cancer checks
Amanda Pritchard says the health service is "open and ready" to treat people, as research shows 60 per cent are concerned about burdening the NHS , with almost half (49 per cent) saying they would delay seeking medical advice currently compared to before the pandemic. Ms Pritchard said: “We know that thousands of people could be risking their lives by delaying medical attention for cancer symptoms. We are open and ready to treat people with potential cancer symptoms.
But, with extra funding and staff that figure could be pushed up to 15 per cent – allowing backlogs could be cleared by next year.
The study lays bare the catastrophic impact of the pandemic on cancer diagnosis and treatment.
During the height of the Covid crisis, from March 2020 to February 2021, 369,000 fewer people than expected were referred to a specialist with suspected cancer.
Video: A&E doctor says morale is plummeting with staff 'absolutely exhausted' as Covid cases rise (Wales Online)
The number of chemotherapy treatments also fell by 187,000, while there were 15,000 fewer radiotherapy treatments.
The report suggests the backlog in chemotherapy and radiotherapy could take until 2028 and 2033 respectively to clear.
More than half of adults unable to name common signs of blood cancer
More than half of British adults cannot identify any symptom of blood cancer, a survey has suggested, as a charity warned some of the signs could be mistaken for COVID-19. © PA More than half of British adults cannot name any symptom of blood cancer, a survey has suggested. File pic. The percentage of people saying they did not know any symptoms of the third biggest cancer killer in the UK has risen by 4% since a similar survey in 2018.Conducted by Blood Cancer UK, the poll found 56% of people could not name any signs - up from 52% of respondents asked three years ago.
There has also been a dramatic drop in diagnostic procedures, with endoscopies down 37 per cent, MRI scans 25 per cent and CT scans ten per cent.
The report said: ‘Behind these statistics are thousands of people for whom it will now be too late to cure their cancer.
‘We estimate that the number of cancers diagnosed while they are still highly curable fell from 44 per cent before the pandemic to 41 per cent last year.’
Early diagnosis and prompt treatment is crucial to survival chances.
Parth Patel, an NHS doctor who led the study, said the pandemic had undone ‘years of progress in cancer survival rates’.
He added: ‘Now the health service faces an enormous backlog of care that threatens to disrupt services for well over a decade.
‘The funding announced this month is just enough to keep the health service afloat, but does not provide the funds to bring down pandemic backlogs as quickly as possible or transform service quality.’
Covid vaccines protect patients with cancer against virus, says new study .
COVID vaccines for cancer patients are just as effective for those reported in the general population, according to the findings of a new study.Public health experts and cancer specialists in the UK have agreed that people living with cancer should receive the vaccine.